Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy — HSTH  

Cancer of Cervix Clinical Trial

Official title: Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

Status Completed

Clinical Trial Summary

Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical biopsy was done and histopathological examinations were done to evaluate the pathology in these patients.

Clinical Trial Description

• Study design and settings: Cross sectional descriptive studies conducted from December 2017 till January 2021.

• Patients: 80 patients with supracervical hysterectomy recruited at Tanta University Hospital, gynecology clinics will be recruited according inclusion and exclusion criteria. Inclusion criteria include all symptomatizing patients following supracervical hysterectomy, of any age, of any complaints. The exclusion criteria were patients with total hysterectomy, hysterectomies for malignant indications, and refusal to participate.

• Methods: All patients' demographic data, history, indication of hysterectomy, duration since operation, postoperative complications and their main complaint.

Intervention: under general anesthesia cervical biopsy (4 quadrants) were taken from all patients and was sent for histopathological examinations. ;

Related Conditions & MeSH terms

• Cancer of Cervix
• Cervicitis
• CIN
• Uterine Cervical Neoplasms
• Uterine Cervicitis

• NCT number: NCT04809727
• Study type: Interventional
• Source: Tanta University
• Status: Completed
• Phase: N/A
• Start date: December 1, 2017
• Completion date: January 31, 2021